Cancer Dialogue Ep. 3: Michael Oberreiter and Ulrika Kagstrom

5 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
In our video series, Cancer Dialogue, we bring together some of the renowned experts in oncology to discuss the latest innovations in cancer care. Learn from experts as we take a deep dive into the hot topics in oncology, exploring the needs, barriers, and opportunities in advancing cancer care.

In our third episode, we met with Michael Oberreiter, working in Global Access, Roche and Ulrika Kagstrom, President of the UICC, Secretary-General of the Swedish Cancer Society, and board member of the Nordic Cancer Union. Michael and Ulrika explore the importance of a multi-stakeholder approach involving both public and private sector organizations to address the complexities of modern cancer challenges. Looking ahead, it's crucial to adopt a more patient-oriented approach that treats the whole person, not just the disease.

To be the first to see new episodes of our Cancer Dialogue series, subscribe to our YouTube channel now: https://www.youtube.com/user/roche

Subscribe to our YouTube channel now: https://www.youtube.com/user/roche?su...

Get in touch with us:

https://www.roche.com/
https://twitter.com/roche
https://www.linkedin.com/company/roche
https://www.facebook.com/roche
https://www.instagram.com/roche

Roche has been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.

Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience.

For more information and insights visit: https://www.roche.com/
Category
Oncology
Be the first to comment

Up Next